A toenail can look noticeably clearer and still be full of fungus. Whether these treatments “work” depends on which outcome you mean: a cosmetic change, or a lab-confirmed cure. Research supports the first far more than the second, and the FDA’s clearance language says so directly.
Not reliably. They have produced real improvements in clinical studies, but cure rates swing so widely across devices, wavelengths, schedules, and organisms that no single protocol is proven.
Diode lasers were the most common light source, generally 450–700 nm, paired with photosensitizers such as methylene blue, aminolevulinic acid, and methyl-5-aminolevulinate.
The review rated randomized evidence moderate-certainty and nonrandomized evidence low-certainty, concluding that standardized trials are still needed.
The combination group received eight diode-laser sessions plus three PDT sessions; the comparison group used daily ciclopirox 8% HPCH.
Home devices tend to skip that detail. PDT is not a lamp pointed at a toe: published protocols pair a photosensitizer with a specific light source, and their results do not transfer to an unsupervised consumer unit.
| Approach | What The Record Shows | Confidence |
|---|---|---|
| Antimicrobial PDT, clinician-administered | Severity scores down roughly 30–90%; clinical cure 20–80% across 18 studies | Moderate for randomized trials, low otherwise |
| PDT plus fractional CO₂ laser | Mycological cure up to 100% in some trials | Low — protocols varied |
| Diode laser plus PDT vs daily ciclopirox 8% | 94.1% vs 53.3% clinical cure, 26 patients | Low — very small sample |
| FDA-cleared lasers under product code PDZ | Temporary increase of clear nail | Cleared indication, no cure claim |
| Consumer UV, blue-light, and red-light units | No matching clinical evidence in these sources | Unproven |
What FDA Clearance Actually Covers
FDA clearance for these devices covers a temporary increase of clear nail — not elimination of fungus, and not a permanent cure.
Nail-fungus lasers sit under product code PDZ, regulation 21 CFR 878.4810, as Class II devices reviewed through the 510(k) pathway. The FDA’s device classification record for onychomycosis lasers spells out that narrow indication. FDA guidance for the category asks manufacturers to demonstrate visual improvement together with negative fungal cultures and stains.
Clearance says nothing about whether a given lamp matches the wavelength, power, treatment geometry, or schedule of a cleared clinical system. A home unit carrying a clearance number is not the same product as a dermatology clinic’s laser.
Why A Diagnosis Comes First
Because trauma, psoriasis, lichen planus, bacterial infection, and other nail disorders all mimic fungus.
Clinical trials and FDA guidance lean on fungal cultures and stains when they judge cure, and that standard applies at home: a visual guess is not a diagnosis. Treat “FDA-cleared” as a regulatory status rather than a promise, since it is neither FDA approval nor a guarantee of cure. Then keep following up after the nail starts looking better, because surface improvement is not evidence that the organism is gone.
If the diagnosis is confirmed and you want to compare hardware on wavelength, build, and price, this roundup of tested nail fungus light treatment options is a sensible next stop.
The order that keeps you from wasting money:
- Get fungus confirmed by a clinician, ideally with a culture or stain.
- Read what a device is cleared to do, not its sales page.
- Weigh clinic PDT plus laser as the evidence-backed route and home lamps as unproven.
- Re-test at follow-up instead of trusting a photograph.
Common Questions
No. Studies vary by fungal organism and rarely break results down by species, one reason cure rates in the 2025 review ranged from 20% to 80%. A device that helped someone else tells you little about your own infection.
Is a home light device as good as a clinic treatment?
The published record does not support that comparison. Clinic protocols pair a photosensitizer with a calibrated light source, and those results should not be applied to unsupervised home units. A home device’s clearance covers a temporary increase of clear nail, not a cure.
How long before you can tell whether it worked?
Longer than most people expect. One trial followed patients for a full 12 months before reporting cure rates, and toenails grow slowly. A clearer nail may simply be healthy nail replacing damaged nail, so assessment needs follow-up and, if a cure is claimed, negative cultures or stains.
Sources
- U.S. Food and Drug Administration. “Product Code PDZ — Lasers for Temporary Increase of Clear Nail.” Defines the cleared indication and device class for onychomycosis lasers.
- National Library of Medicine (PubMed). “Antimicrobial photodynamic therapy for onychomycosis: a systematic review.” Source for the 18-study, 591-participant pooled results and certainty ratings.
- U.S. Food and Drug Administration. “510(k) Premarket Notification K221363 — AF Laser.” Records the July 20, 2022 clearance decision and applicant.